Mode
Text Size
Log in / Sign up
N/A N=119 Randomized Double-blind Treatment

Clinical Evaluation of a Daily Wear Frequent Replacement Silicone Hydrogel Lens

Refractive Errors

Enrolled (actual)
119
Serious AEs
0.2%
Results posted
Feb 2022
Primary outcome: Primary: Distance Visual Acuity (VA) With Study Lenses - Completed Eyes — -0.06; -0.06; -0.06; -0.05 logMAR

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
LID015385 contact lenses (Device); Comfilcon A soft contact lenses (Device); CLEAR CARE (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Alcon Research
Primary completion
Oct 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Distance Visual Acuity (VA) With Study Lenses - Completed Eyes
-0.06; -0.06; -0.06; -0.05; -0.06; -0.06
PRIMARY
Distance Visual Acuity (VA) With Study Lenses - Discontinued Eyes
-0.04; -0.06; -0.02; -0.06; -0.04; -0.05

Summary

The purpose of this clinical study is to demonstrate the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in a daily wear modality.

Eligibility Criteria

Key Inclusion Criteria

  • Successful wear of spherical daily wear frequent replacement soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day.
  • Manifest cylinder ≤ 0.75 diopter (D) in each eye.
  • Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria

  • Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
  • Monovision contact lens wearers.
  • Habitually wearing Biofinity® lenses.
  • Other protocol-specified exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03920280). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search